The PR domain-containing (PRDM) family protein PRDM16 is a key transcriptional 105 regulator in diverse cell types (Kajimura et al. 2008; Chuikov et al. 2010 ; Aguilo et al. 2011) . 106
In embryonic and adult brain, PRDM16 was shown to control neural stem cell 107 maintenance (Chuikov et al. 2010 ; Shimada et al. 2017 ), IP proliferation (Baizabal et al. 2018) , 108 neuronal migration (Inoue et al. 2017; Baizabal et al. 2018 ) and ependymal cell differentiation 109 (Shimada et al. 2017) . It was shown that in these contexts PRDM16 regulates genes involved 110 in reactive oxygen species (ROS) levels (Chuikov et al. 2010; Inoue et al. 2017 ) and epigenetic 111 states of its bound enhancers (Baizabal et al. 2018 ). The PRDM16 protein (Supplemental In this study, we explored the in vivo function of Prdm16 in the developing mouse brain. 119
We show that Prdm16 controls brain development in at least two areas, the ChP and the 120 neocortex. Prdm16 is essential for ChP development. In the neocortex, Prdm16 promotes the 121 shift between L5 neuron and L2-4 neuron specification. PRDM16 sets up the transcriptional 122 landscape for mid-layer and upper-layer specification genes and influences gene expression 123 dynamics of RG between mid-and late-neurogenesis. it co-localizes with the RG marker Sox2 (Supplemental Fig.S1D ). In KO animals, PRDM16 149 staining is lost in the entire brain (Supplemental Fig. S1D ), while in cKO mutants it is depleted 150 in the dorsal telencephalon but remains expressed in the ventral telencephalon and the ChP 151 (Supplemental Fig. S1E) . 152
We first analyzed the cortical laminar organization of the KO brains, by labeling cortical 153 neurons with Satb2 for the upper-layer (L2-4, II-IV) and Ctip2 and Fezf2 for the mid-layer n 154 (L5, V, strong Ctip2 and Fezf2) and the deep-layer (L6, VI, weak Ctip2 and Fezf2). At postnatal 155 day 0 (P0), mutant cortices showed expansion of Ctip2+ layer, accompanied by thinning of 156 Satb2+ upper-layer (Fig. 1A-B) , compared with control cortices. Some Satb2+ neurons 157 scattered inside the deep layer, suggesting that a subset of upper-layer neurons may have failed 158 to migrate. Similarly at E15.5 when upper-layer neurons were just born, the number of Satb2+ 159 neurons was already reduced and the mid-layer neurons labeled with Fezf2 and Ctip2 were 160 expanded in the mutant (Fig. 1C-D) . The reciprocal changes of L5 and L2-4 marker genes were 161 confirmed by reverse transcription followed by quantitative PCR (RT-qPCR). The levels of the 162 two L5 genes increased to about 150%, while those of the L2-4 genes decreased to 50-70% 163 (Fig. 1E) , indicating that gain of mid-layer neurons roughly compensates for loss of upper-164 layer neurons at E15.5. Hence, the Prdm16 KO cortex display two types of defects: over 165 production of mid-layer neurons; compromised neuronal production and defective migration of 166 upper layer neurons. 167
In Prdm16 KO brains, the prospective ChP in the lateral and the 3 rd ventricles are 168 dramatically reduced (Supplemental Fig. S1D, F Fig. 2A-B) . At P15, the cKO cortex showed similar defects on the upper-180 and mid-layer neurons ( Fig. 2C-E) . The Tbr1-labeled deep-layer is unchanged. Some Satb2+ 181 neurons failed to migrate to the upper-layer and were retained below the cortex, as a chunk of 182 grey matter cells (Heterotopia) (Fig. 2C-D (Fig. 2F-G) . In contrast, the mutant cortex appeared supernumerary 202 Ctip2+BrdU+ neurons, suggesting Ctip2+ neurons were produced even at or after E14.5 in the 203 mutant. Notably, the numbers of the Ctip2+BrdU-cells did not differ between control and 204 mutant, indicating that production of Ctip2+ neurons before E14.5 was normal in the mutant. 205
These results demonstrate that some of Prdm16 mutant RG cells failed to transit from E13.5 to 206 E14.5 and continued to produce Ctip2+ neurons at E14.5 (Fig. 2H) . 207
BrdU+ or EdU+ cells were also found in the heterotopia and the deep layer 208 (Supplemental Fig. S2A-C) , confirming that the retained cells were the upper-layer neurons 209 that failed to migrate but not from cell-fate transformation in the deep layer or heterotopia. 210
None of the Ctip2+BrdU+ cells were retained in the deep layer (Fig. 2F) or in the heterotopia 211 (Supplemental Fig. S2B ), suggesting that even the latter-produced Ctip2+ neurons migrate 212 normally and that the migration failure is specific to upper-layer neurons. 213
214

PRDM16 promotes proliferation of intermediate progenitors during late neurogenesis 215
To test if PRDM16 regulates proliferation, we examined RG and IP cell counts at E15.5 216 by labeling RG with Pax6 and IPs with Tbr2. Remarkably, there was a reduction in the number 217 of Tbr2+ IPs in the cKO cortex, whereas Pax6+ RG were not affected ( Fig. 3A-B) . We further 218 assessed proliferation of IP cells by EdU labeling. We injected EdU to pregnant mice with 219 embryos at E15 and analyzed the brains after 12 hours. There was a significant increase of the 220 percentage of Edu+Ki67-cells over all EdU+ cells, indicating more cells exiting cell cycle in 221 mutant ( Fig. 3C-D) . We observed a significant decrease of Ki67+ cells specifically in the 222 mutant SVZ (Fig. 3C, 3E show any change (Supplemental Fig. S3 F) . 235
Together, these findings suggest that PRDM16 regulates RG neurogenesis in a stage 236 specific manner: first, it promotes the temporal transition of RG between E13.5 and E14.5; 237 second, it promotes IP proliferation during late-neurogenesis. 238
PRDM16 modulates levels of neuronal specification genes in RG 239
We hypothesized that PRDM16 may regulate the transcriptional program of RG. To this 240 end, we generated RNA-seq data from E13.5 control and KO mutant forebrains (FB) (Fig. 4A) . 241 We identified 35 downregulated and 47 upregulated genes in KO versus control, using a cutoff 242 of P value < 0.05 and fold-change > 1.5-fold (Supplemental Fig. S4A-B) . We compared our 243 FB RNA-seq data with the published RNA-seq data of sorted RG, IPs and cortical neurons 244 (CNs) from E15.5 control and Emx1
IREScre -mediated Prdm16 cKO cortices (Baizabal et al. 245 2018). Most of the de-regulated genes in the mutant FB were also de-regulated in the E15.5 246 mutant RG (Supplemental Fig. S4A ). Consistent with RG-specific expression of Prdm16, RG 247 is the primary cell type where PRDM16 directly controls gene expression. 248
We next examined expression of layer marker genes in the RNA-seq data ( Neither the mid-layer nor the deep-layer genes showed significant change as a group in 255 the KO FB, despite the expression of three genes, Pcp4, Otx1 and Fezf2, showing mild increase 256 (Fig. 4B) . We reasoned that at E13.5 the mid-and deep-layer neurons are specified and that 257 many of the mid-layer genes are also expressed in the deep-layer, making it hard to reveal cell-258 type specific changes for these genes from whole FB data. To verify the changes, we selected 259
Pou3f2/Brn2 and Unc5D, two upper-layer genes, and Pcp4 and Fezf2, two mid-layer markers 260 for in situ hybridization experiments (Fig. 4C-D) . Expression of Brn2 and Unc5D was reduced 261 in the mutant VZ and SVZ respectively, confirming the reduction of their expression in mutant 262 progenitors. Expression of Pcp4 and Fezf2 showed an increase in the mutant VZ and SVZ, 263 albeit the increase of Fezf2 expression more obvious at E15.5. We also analyzed changes of the 264 layer genes in the published E15.5 RG, IP and CN RNA-seq data (Baizabal et al. 2018) and 265 observed a similar trend: the upper-layer genes are significantly downregulated in all three cell 266 types (Supplemental Fig. S4B ). The mid-layer genes as a group showed significant up-267 regulation in mutant RG and IPs, but not in mutant CN, suggesting these genes may be regulated 268 in progenitors. 269
These results demonstrate that neuronal specification genes are already expressed in 270 progenitors and that their normal expression is disrupted by Prdm16 depletion. 271
272
PRDM16 mainly functions as a transcriptional repressor in RG 273
To determine direct targets of PRDM16 in the developing brain and investigate how the 274 targets are regulated, we performed chromatin immunoprecipitation followed by deep 275 sequencing (ChIP-seq) from E13.5 heads. Using an IDR (Irreproducibility Discovery Rate) 276 pipeline (see Methods), we identified 2319 confident peaks (IDR < 5%), of which 40% were 277 mapped to intergenic regions, 30% to introns and only 20% close to promoters. This result 278
indicates that PRDM16 mainly binds to distal enhancers (Fig. 5A) . Gene Ontology analysis 279
shows that PRDM16-bound genes are enriched for nervous system development, migration 280 signaling and RG function (Supplemental Fig. S5A-B) . We compared our E13.5 whole-head 281
ChIP with the published E15.5 cortex ChIP data (Baizabal et al. 2018) , and found around 30% 282 (798) of the E13.5 peaks overlap with the E15.5 peaks (Supplemental Fig. S5C ). The 283 overlapping sites represent continuous binding by PRDM16 between E13.5 and E15.5. 284
We then analyzed how the targets are regulated by PRDM16. By applying gene set 285 testing for all the targets as a set, we found that the targets in both E13.5 and E15.5 have a 286 significant trend of de-repression in mutant RG (P <0.001) and IPs (P <0.001) but not in CNs 287 (P=0.19) (Fig. 5B) , suggesting that many targets are normally repressed by PRDM16. To 288 confirm the finding from global analysis, we checked a group of genes called RG core identity 289 genes (Yuzwa et al. 2017 ) highly expressed throughout neurogenesis. We found that 20 out of 290 the 90 RG identity genes showed de-regulation in the Prdm16 mutant FB. Only the subset 291 bound by PRDM16 became upregulated in the mutant FB (Fig. 5C) or the mutant RG and IPs 292 (Supplemental Fig. S5D) . 293 We next examined chromatin states of E13.5 control and mutant cortices by using 294 ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) (Buenrostro et al. 295 2013) that measures chromatin accessibility. Higher ATAC-seq signals in the genome correlate 296 with active cis-regulatory elements (Daugherty et al. 2017 ). At PRDM16-bound regions, there 297 is high ATAC-seq intensity that became even higher in the mutant (Fig. 5D) , suggesting that 298 loss of Prdm16 led to increased chromatin accessibility at its targeted sites. We quantified 299 changes of ATAC-seq coverage on the PRDM16 ChIP-seq peaks between control and mutant. 300 226 and 189 peaks respectively showed increased and reduced coverage (FDR<0.2 and FC>1.4-301 fold) (Fig. 5E, Supplemental Fig. S5E ). We then examined expression changes for the genes 302 whose loci associate with accessibility changes. Interestingly, many of the up-regulated genes 303 in E15.5 mutant RG (Fig. 5E) or mutant E13.5 FB (Supplemental Fig. S5E ) had increased 304 chromatin accessibility, whereas down-regulated ones do not show either trend. Validation on 305 one of the genes, Veph1, by RT-qPCR and in situ hybridization confirmed de-repression of 306 Veph1 in Prdm16 mutant (Fig. 5F-H) . Hence, we conclude that PRDM16 primarily acts as a 307 repressor in RG through maintaining accessibility of chromatin. 308
309
PRDM16 directly represses mid-layer genes including Fezf2 310
Since PRDM16 represses transcription, as indicated above, expression of its targets in 311 RG may be relatively low. We then asked in which cell types the target genes have higher 312 expression. To address this, we first re-analyzed the published scRNA-seq data from E13.5 313 (Yuzwa et al. 2017 ) to obtain cell-type specific transcriptomes. We identified 6 clusters and 314 assigned the cell type to each cluster (Supplemental Fig. S6 A-B of PRDM16 targets per cell in each cluster ( Fig. 6A and Supplemental Fig. S6C ). The mid-319 and deep-layer neuron clusters show the highest, suggesting many of the PRDM16 targets are 320 highly expressed in mid-and deep-layer neurons. 321
One of the PRDM16 targets is Fezf2 (Fig. 6B) , a mid-layer neuron determinant 322 (Molyneaux et al. 2005) . PRDM16 binds to the distal enhancers of Fezf2, one of which is known 323 to drive Fezf2 expression in RG (Shim et al. 2012) . We confirmed Fezf2 is de-repressed in 324
Prdm16 KO mutant neural stem cells, using primary NSC culture (Fig. 6C) . We then tested 325 responsiveness of this downstream RG enhancer to PRDM16 using a luciferase reporter driven 326 by the Fezf2 enhancer (Fig. 6D) . PRDM16 fused with an VP64 activation domain induced 327 higher expression of the Fezf2 reporter compared to the pGL3-promoter alone, confirming 328 PRDM16 binding to this enhancer. However, PRDM16 (PRDM16-FL) alone or the truncated 329 version (PRDM16-PRdeletion, lack of the PR domain) did not have effect on the reporter (Fig.  330   6D) . We reasoned that PRDM16 may require chromatin context for its regulatory activity which 331 is lacking in transient transfection assay. To overcome this, we measured the endogenous level 332 of Fezf2 mRNA by RT-qPCR from N2A cells infected with a control construct or with either 333 PRDM16-FL or PRDM16-PRdeletion (Fig. 6E) . Endogenous Fezf2 expression was reduced in 334 cells expressing PRDM16-FL but not in those expressing PRDM16-PRdeletion, suggesting that 335 PRDM16 needs endogenous chromatin context or other cis-regulatory element(s) to repress 336
Fezf2 and the PR domain is essential for its repressive activity. 337
338
PRDM16 influences temporal dynamics of RG gene expression 339
We hypothesized that the gene expression program of E13.5 RG may differ from that 340 of E15.5 RG and that PRDM16 may influence the dynamics of gene expression in RG. To test 341 this, we first identified dynamic genes in RG, by performing differential expression analysis 342 between the E13.5 and the E15.5 RG clusters from the published scRNA-seq data (see Method). 343 120 and 248 genes show higher expression at E13.5 and at E15.5 respectively (FDR < 0.2, 344 FC>1.4-fold) (Fig. 7A) . We then examined gene expression changes of these genes in Prdm16 345 mutant RG (Prdm16 cKO RNA-seq data (Baizabal et al. 2018) ) and found 24 of them showing 346 most significant changes (FDR < 0.05) (Fig. 7B, Supplemental Fig. S7A (Fig. 7D) . 357
As UNC5D is specifically expressed in upper-layer neurons, the potential action between 358 UNC5D and FLRT3 provides a possible mechanism specific for upper-layer neuron migration. 359
These results demonstrate that PRDM16 regulates expression of a subset of temporally-360 dynamic genes which may mediate its roles in promoting temporal transition of RG. However, we found that there is prolonged production of mid-layer neurons in Prdm16 cKO 384 cortex in addition to its effects on upper-layer neurons. The discrepancy may result from the 385 methods used to assess cell fates. We distinguished L5 mid-layer neurons from L6 deep-layer 386 neurons while they assessed L5 and L6 neurons as a whole population. We dissected the 387 regulatory network controlled by PRDM16 at the transition of mid-to late-neurogenesis and 388 identified different classes of genes responsible for PRDM16 functions. We propose a model 389 that includes three key points ( The plasmids used for making stable cell lines, pCDH-Prdm16 and pCDH-Prdm16-494 PRdeletion, were generated as follow: The Prdm16 FL ORF, the PR-deletion coding sequences 495 or the NLS-3xFlag was digested from their pCAGIG plasmids and inserted sequentially to the 496 pCDH-CMV-MCS-EF1-Puro plasmid (System Biosciences) between the EcoRI and NotI sites 497 (for Prdm16-FL and Prdm16-PRdeletion) and the XbaI and EcoRI sites (for NLS-3xFLAG). 498 499
Immunochemistry, BrdU and EdU labelling and confocal imaging 500
At designed stages, embryos or pulps were perfused with PBS followed by 4% 501 paraformaldehyde. The perfused brains were dissected, fixed overnight and sectioned coronally 502 using a vibratome (Leica Microsystems). Immunostaining was done according to standard 503 protocols as previously used (Dai et al. 2013a ). The list of primary secondary antibodies and 504 using condition is provided in supplemental table 4. 505
BrdU (5-bromo-2'-deoxyuridine) and EdU (5-ethynyl-2′-deoxyuridine) (5-20 µg/g of 506 body weight) were injected into the peritoneal cavity of pregnant mice. BrdU incorporation was 507 measured by immunostaing using an antibody against rat-BrdU (Abcam) and mouse-BrdU 508 (DSHB). EdU incorporation was detected with the Click-iT assay (Invitrogen) according to the 509 manufacturer's instructions. Imaging was done on Zeiss confocal microscope. ZEN 510 (ZeissLSM800), ImageJ (NIH) and Photoshop (Adobe) were used for analysis and 511
quantification. 512 513
In situ hybridization 514
The mouse brains at defined ages were dissected and fixed for 12 hours in 4% PFA, 515 cryoprotected in 25% sucrose overnight, embedded in O.C.T, and sectioned at 18 µm on Leica 516 cryostatsCM3050s. RNA in situ hybridization was performed using digoxigenin-labeled 517 riboprobes as described previously. Detailed protocols are available upon request. Images were 518 taken using a Leica DMLB microscope. Prdm16PRdeletion, pCAGIG-Prdm16-VP64, pCAGIG-VP64 or pCAGIG. 2ng of Renilla-555 luciferase construct was used as internal control. After 24-hour incubation, transfected cells 556 were lysed and luciferase activity was measured using Dual Luciferase Assays (Promega), and 557 promoter activity was defined as the ratio between the firefly and Renilla luciferase activities. 558
For generating the cell lines that stably express control, Prdm16-FL or Prdm16-559 PRdeletion, lentiviral particles were first produced in 293T cells and then added to N2A cells 560 for infection. The cells that stably express the corresponding constructs were selected and 561 maintained in medium that contains puromycin. Two individual stable lines were generated for 562 each of the constructs used in RT-qPCR analysis of the Fezf2 gene. 563 564
ChIP-seq analysis 565
In each replicate, three E13.5 control or Prdm16 KO mutant heads were pooled, fixed 566 and lysed. ChIP was performed as previously described (Dai et al. 2013b ). DNA libraries were 567 made using the NEBNext Ultra™ II DNA Library Prep Kit and sequenced on the Illumina 568 Hiseq2500 platform. 569
The replicated Prdm16 KO (x3) and control (x3) ChIP-seq samples, after the adaptor 570 trimming by Trimmomatic, were mapped to the UCSC Mus musculus (mm10) genome 571 assembly using Bowtie2 with the default parameters. The uniquely mapped reads (with 572 mapping quality >= 20) were used for further analysis. The PRDM16 peaks were called by 573 HOMER (v4.10) (Heinz et al. 2010 ). The peak replicate reproducibility was estimated by 574
Irreproducibility Discovery Rate (IDR), using the HOMER IDR pipeline 575 (https://github.com/karmel/homer-idr). As suggested by the Encode IDR guideline that IDR 576 requires to initially call peaks permissively for the replicates, we used a relatively relaxed 577 parameter "-F 2 -fdr 0.3 -P .1 -L 3 -LP .1" for the true/pseudo/pooled replicates by the HOMER 578 peak calling. The final confident peaks were determined by an IDR < 5%. The peaks that were 579 overlapped with mm10 blacklist were also removed. For comparisons, we re-analyzed the 580
Prdm16 control and cKO ChIP-seq public data ( (Baizabal et al. 2018 ); GSE111657) using the 581 same HOMER IDR pipeline. 582 583
RNA-seq differential expression analysis 584
Cortices of control and Prdm16 KO mutant E13.5 embryos were dissected for RNA 585 extraction using Trizol reagent (Invitrogen). RNA quality of three biological replicates was 586 tested by Agilent Bioanalyzer. RNA-seq libraries were made using the Illumina Truseq Total 587 RNA library Prep Kit LT. Sequencing was performed on the Illumina Hiseq2500 platform. 588
After trimming the adaptor sequences using Trimmomatic, we mapped RNA-seq reads 589 from the replicated Prdm16 wild type (x3) and mutant samples (x3) to the UCSC Mus musculus 590 (mm10) genome assembly using HISAT2. We normalized RNA-seq by the "Relative Log 591
Expression" method implemented in the DESeq2 Bioconductor library (Love et al. 2014 ). Gene 592 annotation was obtained from the iGenomes UCSC Mus musculus gene annotation. 593
Differentially expressed mRNAs between Prdm16 mutants versus wild type were identified, 594
and FDR (Benjamini-Hochberg) was estimated, using DESeq2. For comparisons, we re-595 analyzed the differential expression of Prdm16 WT and cKO RNA-seq public data (Baizabal 596 et al. 2018; GSE111660) using the same method as above. The genes with P-value ≤ 0.05 were 597 considered to be differentially expressed. 598
599
ATAC-seq analysis 600
The ATAC-seq libraries were made according to the published method (Buenrostro et 601 al. 2013 ) and using the Illumina Nextera DNA library kit. In brief, cortices were dissected from 602 3 control and 3 Prdm16 KO E13.5 brains. Tn5 enzyme reaction was performed at 37 degrees 603 for 30mins, followed by DNA purification. 11 cycles of PCR amplification was performed 604 using barcoded adaptors and primers on purified DNA template. Libraries were purified and 605 pooled before sequencing with illumina Next-seq platform. The replicated Prdm16 KO (x3) 606 and control (x3) ATAC-seq samples, after the adaptor trimming by Trimmomatic, were mapped 607 to the UCSC Mus musculus (mm10) genome assembly using Bowtie2 with the default 608 parameters. The high quality and uniquely mapped reads (with mapping quality >= 20) were 609 used for further analysis. ATAC-seq differential expression analysis between Prdm16 mutants 610 and wild types on the Prdm16 bound ChIP-seq peaks were performed by Limma R package. 611
The ATAC-seq peak calling was performed by HOMER using the "broad peak" option with 612 parameters "-region -size 1000 -minDist 2500", separately for the mutant and wild type. To 613 compare active enhancers between E13.5 and E15.5, we further re-analyzed the publicly 614 available histone mark H3K27ac Prdm16 ChIP-seq data at E15.5. We called the peaks against 615
Input using "narrow peak" option by HOMER with the default parameters. 616 617
Gene set enrichment testing 618
To test whether a set of genes are significantly changed amongst the differentially 619 expressed (DE) genes from Prdm16 wild type and mutant RNA-seq data, we used gene set 620 testing function "camera" and "mroast" in the R limma package (Ritchie et al. 2015) . We used 621 "camera", a ranking based gene set test accounting for inter-gene correlation, to test whether 622 the layer markers are significantly changed as a set. We used "mroast" (number of rotations = 623 1000), a self-contained gene set test, to test whether the majority of the genes amongst PRDM16 624 targets are significantly up-or down-regulated. We also used "mroast to test which Gene 625 
